Glaxo Joins Other Drugmakers With Russia Balancing Act

GlaxoSmithKline Plc joined other drugmakers in saying it will continue to provide the most essential medicines to Russia and direct all profits from operations in the country to Ukraine relief causes.

The maker of vaccines and treatments for cancer, HIV, asthma and other diseases also plans to stop promoting products in Russia and won’t start any new clinical trials in the country, according to an update on its website Thursday.

Glaxo is among pharma companies including Johnson & Johnson, Merck & Co. and Roche Holding AG that are seeking to strike a balance between international opprobrium over Russia’s invasion of ...